Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients

This study has been completed.
Sponsor:
Collaborator:
Shin Poong Pharmaceuticals
Information provided by:
Medicines for Malaria Venture
ClinicalTrials.gov Identifier:
NCT00422084
First received: January 12, 2007
Last updated: May 19, 2008
Last verified: May 2008